The U.S. Court of Appeals for the Federal Circuit recently issued a non-precedential Rule 36 affirmance of the Patent Trial ...

Stakeholders suggested that while the FDA rule is dead, updates to LDT regulation are coming nonetheless, and the industry should play a lead role in developing them.